KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Boston Scientific (BSX) Net Margin (2016 - 2025)

Historic Net Margin for Boston Scientific (BSX) over the last 17 years, with Q4 2025 value amounting to 12.71%.

  • Boston Scientific's Net Margin rose 3300.0% to 12.71% in Q4 2025 from the same period last year, while for Dec 2025 it was 14.44%, marking a year-over-year increase of 33700.0%. This contributed to the annual value of 14.44% for FY2025, which is 33700.0% up from last year.
  • Boston Scientific's Net Margin amounted to 12.71% in Q4 2025, which was up 3300.0% from 14.91% recorded in Q3 2025.
  • Over the past 5 years, Boston Scientific's Net Margin peaked at 15.75% during Q2 2025, and registered a low of 2.56% during Q4 2021.
  • In the last 5 years, Boston Scientific's Net Margin had a median value of 11.51% in 2021 and averaged 10.0%.
  • Its Net Margin has fluctuated over the past 5 years, first soared by 201700bps in 2021, then plummeted by -86800bps in 2022.
  • Quarter analysis of 5 years shows Boston Scientific's Net Margin stood at 2.56% in 2021, then surged by 52bps to 3.89% in 2022, then soared by 249bps to 13.56% in 2023, then fell by -9bps to 12.39% in 2024, then increased by 3bps to 12.71% in 2025.
  • Its Net Margin stands at 12.71% for Q4 2025, versus 14.91% for Q3 2025 and 15.75% for Q2 2025.